Adjournment debate on Thursday, 29 January 2015, in the House of Commons, led by Andrew Miller. The answering members were Baroness Berger and Jane Ellison.

Blood Safety (Variant Creutzfeldt-Jakob Disease)

Debate on a Select Committee report. Chosen by the Liaison Committee (thirteenth allotted day). Agreed to on question.

Secondary information

Type: Parliamentary proceeding
Reference: 591 cc354-376WH
Session: 2014-15
Department: Department of Health
Chamber / Committee: Westminster Hall
Related items: After the storm? UK blood safety and the risk of variant Creutzfeld-Jakob disease: Science and Technology Committee second report with formal minutes.
Wednesday, 16 July 2014
Parliamentary committees
House of Commons; Government Response to the Second Report from the House of Commons Science and Technology Committee, Session 2014–15, After the storm? UK blood safety and the risk of variant Creutzfeldt-Jacob Disease
Friday, 17 October 2014
Command papers
House of Lords
House of Commons
Proceeding contributions: Andrew Miller | 591 cc356-8WH (Link to this contribution)
On behalf of the Select Committee, let me say that it is a pleasure to introduce our report “Afte...; Paul Beresford | 591 c358WH (Link to this contribution)
As a slight variation on the hon. Gentleman’s theme, it is not metal, because actually the prion ...; Andrew Miller | 591 cc358-360WH (Link to this contribution)
The hon. Gentleman follows this matter with great care. He is absolutely right, but I am trying t...; Paul Beresford | 591 cc360-2WH (Link to this contribution)
I will try to be succinct after such a full introduction. That is probably possible. I can hear s...; Frank Dobson | 591 cc361-5WH (Link to this contribution)
I start by declaring two peculiar interests. When I was Secretary of State for Health, I introduc...; Baroness Berger | 591 cc365-7WH (Link to this contribution)
It is a pleasure, as always, to serve under your chairmanship, Sir David. I thank the Chair of th...; Paul Beresford | 591 c367WH (Link to this contribution)
To be fair, I think that the hon. Lady should recognise that the RelyOn is not in a state in whic...; Baroness Berger | 591 cc367-8WH (Link to this contribution)
I thank the hon. Gentleman and hope that the Minister will deal with that point. She could perhap...; Jane Ellison | 591 c368WH (Link to this contribution)
It is a pleasure to serve under your chairmanship, Sir David. Sadly, I have been left with less t...; David Amess | 591 c368WH (Link to this contribution)
Order. The debate goes on until 4.30 pm.; Jane Ellison | 591 cc368-9WH (Link to this contribution)
Marvellous. My mistake. In that case, I have plenty of time.
In case there is anything I ca...; Frank Dobson | 591 c369WH (Link to this contribution)
Would you like to try mine?; Jane Ellison | 591 cc369-370WH (Link to this contribution)
Let’s see how I get on, although I thank the right hon. Gentleman for that kind offer.
Firs...; Frank Dobson | 591 c370WH (Link to this contribution)
Will the Minister confirm that none of the scientific advisers has advised her or any other Minis...; Jane Ellison | 591 c370WH (Link to this contribution)
I will say a few words about some aspects of the Collinge work later, but I want to focus on givi...; Paul Beresford | 591 c370WH (Link to this contribution)
In the early days of research, a number of different tests were brought forward. To my knowledge,...; Jane Ellison | 591 c370WH (Link to this contribution)
I will come on to talk about the assay in some detail.; Andrew Miller | 591 c370WH (Link to this contribution)
I find the Minister’s remarks somewhat surprising. As I said in my opening remarks, the Governmen...; Jane Ellison | 591 cc370-2WH (Link to this contribution)
I will update the Select Committee further. We have already committed to submit an additional pie...; Paul Beresford | 591 c372WH (Link to this contribution)
Of course, the results would be anonymised, so the effect on individuals would not be apparent.; Jane Ellison | 591 cc372-3WH (Link to this contribution)
Let me move through the second question; I will be very happy to pick up on any further things in...; Paul Beresford | 591 c373WH (Link to this contribution)
I thank the Minister and apologise for being persistent. DuPont undertook the work because it tho...; Jane Ellison | 591 cc373-4WH (Link to this contribution)
I understand the point. We have debated it before, and it was explored in the meeting with him an...; Andrew Miller | 591 cc374-6WH (Link to this contribution)
I thank right hon. and hon. Members for participating in the debate, which has been about a hugel...
Subjects: Contamination Blood Innovation Disease control CJD
Link: View this Parliamentary proceeding on www.publications.parliament.uk

Blood Safety (Variant Creutzfeldt-Jakob Disease)

Secondary information

Librarians' tools